Eisai Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other
companies in this sector in Japan:
Shionogi & Co Ltd
sales of 309.97 billion Japanese Yen [US$2.71 billion]
of which 100%
Taisho Pharmaceutical Holdings Co Ltd
(290.14 billion Japanese Yen [US$2.53 billion]
of which 62%
was Self-medication), and
Mitsubishi Tanabe Pharma Corp
(431.70 billion Japanese Yen [US$3.77 billion]
Eisai Company Limited reported sales of ¥547.92 billion (US$4.78 billion)
March of 2016.
decrease of 0.1%
versus 2015, when the company's sales were ¥548.47 billion.